Professional Medical Expertise Co.

Professional Medical Expertise Co.

TTADAWUL:9574
78.40
SAR
-1.30
(-1.63%)
294.00MMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
50.3
71.46
89.48
119.65
- -
Basic EPS, GAAP
5.43
7.1
7.9
11.92
- -
Free Cash Flow per Basic Share
-2.98
-0.89
-2.42
-6.72
- -
Dividend per Share
4.57
- -
2.85
1
- -
Book Value per Share
20.91
27.77
32.34
42.92
49.86
Tangible Book Value per Share
20.91
27.77
32.34
42.92
49.12
Basic Weighted Avg Shares
4
4
4
4
4
Sales/Revenue/Turnover
176
250
313
419
- -
Operating Margin (%)
14.77
13.33
12.68
14.43
- -
Depreciation Expense
3
5
7
9
- -
Net Income, GAAP
19
25
28
42
- -
Effective Tax Rate (%)
8.88
8.72
7.87
8.7
- -
Profit Margin (%)
10.8
9.93
8.83
9.96
- -
Working Capital
69
90
111
140
163
LT Debt
2
3
1
2
1
Total Equity
73
97
113
150
175
Return on Invested Capital (%)
- -
21.87
20.52
23.4
- -
Return on Capital (%)
- -
21.25
15.28
17.61
- -
Return on Common Equity (%)
- -
29.16
26.28
31.67
- -

Capital Structure

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
109
124
105
LT Borrowings
- -
- -
- -
LT Finance Leases
2
2
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
308
340
294

Working Capital

SAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
359
394
436
Cash, Cash Equivalents & STI
7
4
9
Accounts Receivable, Net
184
225
253
Inventories
152
152
149
Total Current Liabilities
236
255
273
Payables & Accruals
- -
- -
- -
ST Debt
109
124
105
Deferred Revenue
- -
- -
- -

Growth Rates

SAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
32.69%
Free Cash Flow
- -
- -
178.12%
Net Income, GAAP
- -
- -
50.84%
Sales/Revenue/Turnover
- -
- -
33.72%
Total Cash Common Dividend
- -
- -
-64.91%

Semi-annual Revenue

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
313
2025
- -
- -
419
2026
- -
- -
- -

Semi-annual Earnings Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
7.9
2025
- -
- -
11.92
2026
- -
- -
- -

Semi-annual Dividends Per Share

SAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2.85
2025
- -
- -
1
2026
- -
- -
- -

Company Description

CEO
Amr Mahmoud Abou ElAmayem
Full Time Employees
130
Sector
Distribution services
Industry
Medical distributors
Address
Rawdah Bussiness Center Jeddah MC Saudi Arabia 23434
IPO Date
Jul 26, 2023
Business
Professional Medical Expertise Company Professional Medical Expertise Company (ProMedEx), a Saudi joint stock company founded in 2010 and headquartered in Jeddah, Kingdom of Saudi Arabia, operates as a distributor of medical devices and equipment across the GCC region, including offices in the United Arab Emirates and expansion plans into Bahrain and Kuwait. The company offers a comprehensive portfolio of products encompassing spine solutions, sports medicine, pediatric orthopedics, oncology, general surgery, endoscopy, bariatric surgery, infection prevention, gastrointestinal treatments, women's health, critical care, diabetes management, and dental care units; it also provides pharmaceutical warehousing, legal representation for medical device manufacturers, installation services for hospitals and medical centers, and trading in medical, surgical instruments and supplies to both private and public healthcare facilities primarily in Saudi Arabia and the UAE. In recent developments, ProMedEx signed a memorandum of understanding in June 2025 with Zhende Medical Co., Ltd. and MedSurg FZ-LLC to establish a joint venture in Saudi Arabia, secured SAR 45 million in financing from Saudi Awwal Bank in August 2025, inked a SAR 15 million supply deal with Finland's Serres Oy in July 2025, renewed and increased Islamic financial facilities with Riyad Bank and Banque Saudi Fransi in early 2025, recommended and approved a 10% cash dividend for fiscal year 2024 in April-June 2025, and proposed a SAR 70 million capital increase via rights issue in October 2025.